Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03294642 · ClinicalTrials.gov registry record · NA

Potato Ingestion and Time-trial Performance

A NA study of Exercise Performance, sponsored by University of Illinois at Urbana-Champaign.

Completed
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT03294642: Completed NA study of Exercise Performance, sponsored by University of Illinois at Urbana-Champaign.

NCT03294642 is a NA study of Exercise Performance that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 12 participants, below the 31-participant average among 7 other Exercise Performance trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03294642, a NA study of Exercise Performance, has completed, sponsored by University of Illinois at Urbana-Champaign.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

This research study evaluates the feasibility and appropriateness of potatoes as an ergogenic aid in comparison to the currently promoted sports gels during a cycling challenge and time trial. Using a crossover design, trained cyclists will complete three separate cycling challenges and subsequent time trials in which they will consume either potatoes, commercially available sports gels, or water only.

Primary Outcome

Comparison of time trial performance times between potatoes and sports gel conditions to determine effectiveness of potatoes as an ergogenic aid.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Water
  • DIETARY_SUPPLEMENT Potatoes
  • DIETARY_SUPPLEMENT Carbohydrate Gel

Study Locations (1)

Illinois

  • Freer Hall - Urbana

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2017-09-29
Est. Completion 2019-09-29
Phase NA

What the finished NCT03294642 record still lists

NCT03294642 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 31-participant average among 7 other Exercise Performance trials with a reported enrollment target (61% lower).

The record links to 1 condition, with Exercise Performance appearing as the primary indexed condition, and to 3 interventions - of which Water is the first listed.

NCT03294642 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT03294642 about?

NCT03294642 is a clinical study titled "Potato Ingestion and Time-trial Performance". This research study evaluates the feasibility and appropriateness of potatoes as an ergogenic aid in comparison to the currently promoted sports gels during a cycling challenge and time trial. Using a crossover design, trained cyclists will complete three separate cycling challenges and subsequent t...

What is the current status of trial NCT03294642?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2017-09-29. Estimated completion is 2019-09-29.

What conditions does trial NCT03294642 study?

This clinical trial studies the following conditions: Exercise Performance.

What interventions are being tested in trial NCT03294642?

The interventions under investigation include: Water (DIETARY_SUPPLEMENT), Potatoes (DIETARY_SUPPLEMENT), Carbohydrate Gel (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03294642?

This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03294642 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Exercise Performance

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03294642, the US trial registry maintained by the National Library of Medicine. NCT03294642 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.